Document text
Principal Investigator: Jason Edward Shoemaker
Organization: UNIVERSITY OF PITTSBURGH AT PITTSBURGH
Fiscal Year: 2023
Award: $253,510
Funding agency: National Institute of Allergy and Infectious Diseases
ABSTRACT
Respiratory viruses, such as influenza and SARS-CoV-2, interact with distinct molecular pathways in human
cells to promote virus replication and alter immune activity. When considering patient cohort variability, morbidity
and mortality are often higher for women than men for select influenza virus infections, exemplified in the 2009
H1N1 pandemic. Estradiol, a major sex hormone, has been shown to impact virus replication in a sex-specific
manner. Yet much remains unknown as to the pathways different viruses engage to promote infection and alter
immune activity or what pathways link estradiol activity to virus replication. This research program uses recently
developed bioinformatics algorithms and NIAID-supported, published datasets in order to reveal new pathways
and molecules involved in infection with influenza viruses and SAR-CoV-2 (Aim 1) and in infection in respiratory
cells derived from women and treated with estradiol (Aim 2). More specifically, we will use two dynamic network
perturbation algorithms, ProTINA and DeltaNeTS+, to create dynamic mathematical models of intracellular
signaling in order to predict important disease modulators. Dynamic network perturbation analysis will be applied
to virus-specific, virus-host interaction networks and host gene expression data induced by each virus. For Aim
2, we have identified gene expression data from influenza-infected nasal cells from female donors that are
pretreated with estradiol. We will validate ProTINA’s and DeltaNeTS+ ability to identify host factors of virus
replication using results from published siRNA- and CRISPR-based screens. After the validation, we will perform
an in-depth characterization of the most significant proteins identified in order to generate new hypothesis on the
host pathways that are involved in infection with different respiratory viruses or that interact with estradiol during
infection.
Terms: <2019 novel corona virus><2019 novel coronavirus><2019-nCoV><Address><Adoption><Affect><Age Years><Airway infections><Algorithms><Aquadiol><Automobile Driving><Binding><Bio-Informatics><Bioinformatics><COVID-19><COVID-19 virus><COVID19><COVID19 virus><CRISPR editing screen><CRISPR screen><CRISPR-based screen><CRISPR/Cas9 screen><CV-19><CV19><Cell Body><Cell Communication and Signaling><Cell Signaling><Cells><Cessation of life><CoV-2><CoV2><Code><Coding System><Communicable Diseases><Communities><Computer Analysis><Data><Data Set><Death><Development><Dimenformon><Diogyn><Diogynets><Disease><Disorder><Drug resistance><Endocrine Gland Secretion><Epidemiology><Epithelial Cells><Estrace><Estradiol><Estradiol-17 beta><Estradiol-17beta><Estraldine><Female><Future><Gene Expression><Genomics><Goals><Gonadal Steroid Hormones><Grippe><H1N1><H1N1 Virus><H3N2><H3N2 Virus><Hormones><Hospital Admission><Hospitalization><Host Factor><Host Factor Protein><Human><Immune><Immune response><Immunes><Immunological response><Infection><Infectious Disease Pathway><Infectious Diseases><Infectious Diseases / Laboratory><Infectious Diseases Research><Infectious Disorder><Inflammatory><Inflammatory Response><Influenza><Influenza A Virus, H1N1 Subtype><Influenza A Virus, H3N2 Subtype><Influenza Virus><Integration Host Factors><Intracellular Communication and Signaling><Knowledge><Link><Math Models><Mediating><Modern Man><Molecular><Molecular Interaction><Morbidity><Morbidity - disease rate><NIAID><Nasal><Nasal Epithelium><Nasal Passages Nose><National Institute of Allergy and Infectious Disease><Natural regeneration><Nose><Ovocyclin><Ovocylin><Pathway interactions><Patients><Policies><Process><Progynon><Proteins><Publishing><Regeneration><Research><Respiratory Infections><Respiratory System, Nose, Nasal Passages><Respiratory Tract Infections><SARS corona virus 2><SARS-CO-V2><SARS-COVID-2><SARS-CoV-2><SARS-CoV2><SARS-associated corona virus 2><SARS-associated coronavirus 2><SARS-coronavirus-2><SARS-related corona virus 2><SARS-related coronavirus 2><SARSCoV2><Severe Acute Respiratory Coronavirus 2><Severe Acute Respiratory Distress Syndrome CoV 2><Severe Acute Respiratory Distress Syndrome Corona Virus 2><Severe Acute Respiratory Distress Syndrome Coronavirus 2><Severe Acute Respiratory Syndrome CoV 2><Severe Acute Respiratory Syndrome-associated coronavirus 2><Severe Acute Respiratory Syndrome-related coronavirus 2><Severe acute respiratory syndrome associated corona virus 2><Severe acute respiratory syndrome coronavirus 2><Severe acute respiratory syndrome related corona virus 2><Sex Hormones><Sex Steroid Hormones><Short interfering RNA><Signal Transduction><Signal Transduction Systems><Signaling><Small Interfering RNA><Therapeutic Estradiol><Therapeutic Hormone><Time><Validation><Viral Burden><Viral Load><Viral Load result><Virus><Virus Replication><Woman><Work><Wuhan coronavirus><adult youth><assess effectiveness><biological signal transduction><clustered regularly interspaced short palindromic repeats screen><cohort><computational analyses><computational analysis><computer analyses><corona virus disease 2019><coronavirus disease 2019><coronavirus disease 2019 virus><coronavirus disease-19><coronavirus disease-19 virus><coronavirus infectious disease-19><determine effectiveness><develop therapy><developmental><driving><drug candidate><drug resistant><effectiveness assessment><effectiveness evaluation><entire genome><epidemiologic><epidemiological><evaluate effectiveness><examine effectiveness><experience><flu infection><flu virus infection><full genome><gonadal steroids><hCoV19><host response><human data><immune system response><immunoresponse><in silico><infected with flu><infected with flu virus><infected with influenza><infected with influenza virus><influenza infection><influenza virus infection><influenzavirus><intervention development><mathematic model><mathematical model><mathematical modeling><men><molecular drug target><molecular pharmacotherapy target><mortality><nCoV2><novel><pandemic><pandemic disease><pathogen><pathway><patient variability><patient variation><pressure><programs><regenerate><resistance to Drug><resistant to Drug><respiratory><respiratory infection virus><respiratory virus><response><seasonal flu><seasonal influenza><secondary analysis><sex><sex steroid><siRNA><therapeutic candidate><therapeutic target><therapy development><treatment development><validations><variability between patients><variation between patients><viral multiplication><viral replication><virus host interaction><virus multiplication><whole genome><young adult><young adulthood>